Neuraly Competitors and Similar CompaniesClear all
Neuraly's competitors and similar companies include ACADIA Pharmaceuticals, Jiksak Bioengineering, Erisyon and VistaGen Therapeutics.
 Neuraly Neuraly is a clinical-stage biotechnology company that specializes in the development of drugs for neurodegenerative diseases. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Jiksak Bioengineering Jiksak Bioengineering is a biotechnology company developing nerve tissue products for neurodegenerative diseases. |  VistaGen Therapeutics VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products. | ||
Founding Date | Founding Date 2016 | Founding Date 1993 | Founding Date 2017 | Founding Date 2018 | Founding Date 1998 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Gaithersburg, US HQ | Locations San Diego, US HQ Princeton, US | Locations Kawasaki, JP HQ | Locations Austin, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 186% increase | Employees 513 | Employees 4 | Employees 167% increase | Employees 9 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 82.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $486k (FY, 2025) |
Net income | Net income N/A | Net income $391m (FY, 2025) | Net income N/A | Net income N/A | Net income ($51.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 36m | Total funding raised $ 770.8m | Total funding raised $ 1.8m | Total funding raised N/A | Total funding raised $ 10m |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companyJiksak Bioengineering
HQ
Kawasaki, JP
Employees
4
Jiksak Bioengineering is a biotechnology company developing nerve tissue products for neurodegenerative diseases.
View company
Erisyon
HQ
Austin, US
Employees
16↑ 7% increase
Erisyon is a biotechnology company commercializing a single-molecule protein sequencer.
View companyVistaGen Therapeutics
HQ
South San Francisco, US
Employees
9
VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products.
View company